SELLAS Life Sciences Group Inc. (SLS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    SELLAS Life Sciences Grou...

    NASDAQ: SLS · Real-Time Price · USD
    1.63
    0.02 (1.24%)
    At close: Sep 26, 2025, 3:59 PM
    1.64
    0.61%
    After-hours: Sep 26, 2025, 07:59 PM EDT

    SELLAS Life Sciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 1M 7.6M
    Cost of Revenue
    		 n/a n/a 100K 200K
    Gross Profit
    		 n/a n/a 900K 7.4M
    Operating Income
    		 -31.51M -37.87M -41.95M -25.29M
    Interest Income
    		 632K 525K 317K 6K
    Pretax Income
    		 -30.88M -37.34M -41.3M -20.94M
    Net Income
    		 -30.88M -37.34M -41.3M -20.7M
    Selling & General & Admin
    		 12.42M 13.86M 12.58M 11.32M
    Research & Development
    		 19.1M 24.01M 30.27M 21.37M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 31.51M 37.87M 42.85M 32.69M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 31.51M 37.87M 42.95M 32.89M
    Income Tax Expense
    		 n/a n/a n/a -237K
    Shares Outstanding (Basic)
    		 612.02M 249.99M 19.4M 15.48M
    Shares Outstanding (Diluted)
    		 612.02M 249.99M 19.4M 15.48M
    EPS (Basic)
    		 -0.05 -0.15 -2.13 -1.34
    EPS (Diluted)
    		 -0.05 -0.15 -2.13 -1.34
    EBITDA
    		 -30.88M 529K -31.95M -19.59M
    EBIT
    		 -30.88M -37.34M -31.95M -19.59M
    Depreciation & Amortization
    		 31.51M 37.87M 457K 1.27M

    Add to Watchlist